Sign inGet started

Stilwell McDavid

Insider CIK 1851389 · CHRS Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CHRS Coherus BioSciences, Inc. F Tax w/h2023-12-312024-01-0318,440$3.33 $61.4K75,305SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2023-06-132023-06-1570,000— $070,000SEC↗
CHRS Coherus BioSciences, Inc. F Tax w/h2023-04-012023-04-043,457$6.84 $23.6K102,252SEC↗
CHRS Coherus BioSciences, Inc. A Award2023-01-202023-01-2440,000— $0104,243SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2023-01-042023-01-0680,000— $080,000SEC↗
CHRS Coherus BioSciences, Inc. F Tax w/h2023-01-042023-01-065,437$9.87 $53.7K64,243SEC↗
CHRS Coherus BioSciences, Inc. F Tax w/h2022-04-012022-04-053,458$12.85 $44.4K69,680SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2022-01-042022-01-0680,000— $080,000SEC↗
CHRS Coherus BioSciences, Inc. A Award2022-01-042022-01-0640,000— $073,138SEC↗
CHRS Coherus BioSciences, Inc. S Sale2021-10-152021-10-193,507$16.80 $58.9K31,611SEC↗
CHRS Coherus BioSciences, Inc. P Buy2021-06-092021-06-103,700$13.42 $49.7K35,118SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2021-04-282021-04-3050,000— $050,000SEC↗
CHRS Coherus BioSciences, Inc. A Award2021-04-282021-04-3020,000— $030,000SEC↗